Journey Medical (DERM) Depreciation & Amortization (CF) (2020)
Journey Medical's (DERM) quarterly Depreciation & Amortization (CF) came in at $1000.0 in Q4 2020, little changed on a QoQ basis from $1000.0 in Q3 2020.
Journey Medical (DERM) Depreciation & Amortization (CF) (2020) Analysis & Trends
Journey Medical (DERM) has 1 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q4 2020.
- Quarterly Depreciation & Amortization (CF) changed N/A year-over-year to $1000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $1000.0 (changed N/A YoY) and the FY2020 annual result came in at $5000.0, changed N/A from the prior year.
- Depreciation & Amortization (CF) held at $1000.0 in Q4 2020, from $1000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1000.0 in Q3 2020 to a low of $1000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Journey Medical | 212.53 Mn | 186.88 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |